Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13405* | 2021 |
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part II SF Zhou Clinical Pharmacokinetics 48 (12), 761-804, 2009 | 1143 | 2009 |
Polymorphism of human cytochrome P450 enzymes and its clinical impact SF Zhou, JP Liu, B Chowbay Drug Metabolism Reviews 41 (2), 89-295, 2009 | 951 | 2009 |
Herb-drug interactions: a literature review Z Hu, X Yang, PCL Ho, SY Chan, PWS Heng, E Chan, W Duan, HL Koh, ... Drugs 65, 1239-1282, 2005 | 891 | 2005 |
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4 SF Zhou Current Drug Metabolism 9 (4), 310-322, 2008 | 778 | 2008 |
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition SF Zhou Xenobiotica 38 (7-8), 802-832, 2008 | 759 | 2008 |
Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources SY Pan, G Litscher, SH Gao, SF Zhou, ZL Yu, HQ Chen, SF Zhang, ... Evidence-Based Complementary and Alternative Medicine 2014 (Volume 2014 …, 2014 | 688 | 2014 |
New perspectives on how to discover drugs from herbal medicines: CAM′ S outstanding contribution to modern therapeutics SY Pan, SF Zhou, SH Gao, ZL Yu, SF Zhang, MK Tang, JN Sun, DL Ma, ... Evidence‐Based Complementary and Alternative Medicine 2013 (1), 627375, 2013 | 678 | 2013 |
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs SF Zhou, SY Chan, BC Goh, E Chan, W Duan, M Huang, HL McLeod Clinical Pharmacokinetics 44 (3), 279-304, 2005 | 600 | 2005 |
Herbal modulation of P‐glycoprotein SF Zhou, LY Lim, B Chowbay Drug Metabolism Reviews 36 (1), 57-104, 2004 | 519 | 2004 |
Interactions of herbs with cytochrome P450 SF Zhou, Y Gao, W Jiang, M Huang, A Xu, JW Paxton Drug Metabolism Reviews 35 (1), 35-98, 2003 | 504 | 2003 |
Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring SF Zhou, CC Xue, XQ Yu, C Li, G Wang Therapeutic Drug Monitoring 29 (6), 687-710, 2007 | 438 | 2007 |
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development SF Zhou, LL Wang, YM Di, CC Xue, W Duan, CG Li, Y Li Current Medicinal Chemistry 15 (20), 1981-2039, 2008 | 433 | 2008 |
Effects of Ganopoly® (A ganoderma lucidum polysaccharide extract) on the immune functions in advanced‐stage cancer patients Y Gao, SF Zhou, W Jiang, M Huang, X Dai Immunological Investigations 32 (3), 201-215, 2003 | 414 | 2003 |
Molecular mechanisms for tumor resistance to chemotherapy ST Pan, ZL Li, ZX He, JX Qiu, SF Zhou Clinical and Experimental Pharmacology and Physiology 43 (8), 723-737, 2016 | 403 | 2016 |
Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes JS Bian, QC Yong, TT Pan, ZN Feng, MY Ali, SF Zhou, PK Moore Journal of Pharmacology and Experimental Therapeutics 316 (2), 670-678, 2006 | 398 | 2006 |
Herbal bioactivation: the good, the bad and the ugly SF Zhou, HL Koh, Y Gao, Z Gong, EJD Lee Life Sciences 74 (8), 935-968, 2004 | 361 | 2004 |
Pharmacokinetic interactions of drugs with St John’s wort SF Zhou, E Chan, SQ Pan, M Huang, EJD Lee Journal of Psychopharmacology 18 (2), 262-276, 2004 | 345 | 2004 |
Drug bioactivation covalent binding to target proteins and toxicity relevance SF Zhou, E Chan, W Duan, M Huang, YZ Chen Drug Metabolism Reviews 37 (1), 41-213, 2005 | 325 | 2005 |
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2 SF Zhou, B Wang, LP Yang, JP Liu Drug Metabolism Reviews 42 (2), 268-354, 2010 | 297 | 2010 |